Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
A549
|
72697
|
Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53.
|
Biomolecules |
2021-12-9 |
Pubmed
Full text
|
Human and Animal Cells
|
293T(RCB2202)
|
72683
|
Neuroplastin-β mediates S100A8/A9-induced lung cancer disseminative progression.
|
Mol Carcinog |
2019-6-1 |
Pubmed
Full text
|
Human and Animal Cells
|
WI-38(RCB0704)
|
71760
|
DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment.
|
Oncol Rep |
2008-11-1 |
Pubmed
|
Human and Animal Cells
|
WI-38(RCB0702)
|
71658
|
Imatinib mesylate inhibits the proliferation-stimulating effect of human lung cancer-associated stromal fibroblasts on lung cancer cells.
|
Int J Oncol |
2010-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
A549(RCB0098)
|
71599
|
Novel Inhibitor for Downstream Targeting of Transforming Growth Factor-β Signaling to Suppress Epithelial to Mesenchymal Transition and Cell Migration.
|
Int J Mol Sci |
2022-5-2 |
Pubmed
Full text
|
Human and Animal Cells
|
A549
,
PC-9(RCB4455)
|
70118
|
Repression of RhoJ expression promotes TGF-β-mediated EMT in human non-small-cell lung cancer A549cells.
|
Biochem Biophys Res Commun |
2021-8-20 |
Pubmed
Full text
|
Human and Animal Cells
|
A549(RCB0098)
,
PC-9(RCB4455)
|
69758
|
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma.
|
Cancer Sci |
2021-12-1 |
Pubmed
Full text
|
Human and Animal Cells
|
A549(RCB0098)
|
69581
|
DAP3 Is Involved in Modulation of Cellular Radiation Response by RIG-I-Like Receptor Agonist in Human Lung Adenocarcinoma Cells.
|
Int J Mol Sci |
2021-1-3 |
Pubmed
Full text
|
Human and Animal Cells
|
RERF-LC-AI(RCB0444)
,
A549(RCB0098)
|
69572
|
Increased expression of REV7 in small cell lung carcinomas and its association with tumor cell survival and proliferation.
|
Pathol Int |
2021-1-1 |
Pubmed
Full text
|
Human and Animal Cells
|
LM8(RCB1450)
|
69470
|
The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression.
|
Anticancer Res |
2021-10-1 |
Pubmed
Full text
|
Human and Animal Cells
|
G-361(RCB0991)
,
SK-MEL-28(RCB1930)
,
COLO 679(RCB0989)
,
HMV-II(RCB0777)
|
69262
|
Actin-binding protein, Espin: a novel metastatic regulator for melanoma.
|
Mol Cancer Res |
2014-3-1 |
Pubmed
Full text
|
DNA material
|
CSII-CMV-MCS (RDB04377)
,
CS-RfA-CMV-mRFP1 (RDB05747)
,
pCAG-HIVgp (RDB04394)
,
pCMV-VSV-G-RSV-Rev (RDB04393)
|
68874
|
Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.
|
Sci Rep |
2016-6-13 |
Pubmed
Full text
|
Human and Animal Cells
|
A549(RCB0098)
|
68867
|
Effects of histone deacetylase inhibitors Tricostatin A and Quisinostat on tight junction proteins of human lung adenocarcinoma A549 cells and normal lung epithelial cells.
|
Histochem Cell Biol |
2021-6-1 |
Pubmed
Full text
|
Human and Animal Cells
|
A549(RCB0098)
,
LC-2/ad(RCB0440)
,
RERF-LC-KJ(RCB1313)
|
68848
|
MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
|
Mol Cancer Ther |
2014-2-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68844
|
Design, synthesis and evaluation of the osimertinib analogue (C-005) as potent EGFR inhibitor against NSCLC.
|
Bioorg Med Chem |
2018-12-15 |
Pubmed
Full text
|
Human and Animal Cells
|
Ba/F3
|
68843
|
Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib.
|
Clin Cancer Res |
2014-11-15 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68842
|
Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer.
|
Cancer Sci |
2021-9-1 |
Pubmed
Full text
|
Human and Animal Cells
|
Ba/F3(RCB4476)
|
68837
|
Lamellarin 14, a derivative of marine alkaloids, inhibits the T790M/C797S mutant epidermal growth factor receptor.
|
Cancer Sci |
2021-5-1 |
Pubmed
Full text
|
Human and Animal Cells
|
PC-9(RCB4455)
|
68836
|
Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.
|
Cancer Biol Ther |
2012-4-1 |
Pubmed
Full text
|
Human and Animal Cells
|
Lu-130(RCB0465)
|
68749
|
PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer.
|
Sci Rep |
2013-1-1 |
Pubmed
Full text
|